Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Coda Octopus	CODA	22. nov 2024	9.32	-1.58
Codere Online Luxembourg	CDRO	22. nov 2024	7.60	+4.11
Codexis	CDXS	22. nov 2024	4.61	+6.47
Coeptis Therapeutics	COEP	22. nov 2024	0.19	+2.48
Coeur Mining	CDE	22. nov 2024	6.57	-0.91
Coffee Holding Company	JVA	22. nov 2024	3.49	-3.72
Cogent Biosciences	COGT	22. nov 2024	9.13	+1.67
Cogent Communications	CCOI	22. nov 2024	83.16	-0.76
Cognex	CGNX	22. nov 2024	40.67	+3.75
Cognition Therapeutics	CGTX	22. nov 2024	0.43	-2.75
Cognizant Technology Solutions A	CTSH	22. nov 2024	79.54	+0.86
Cognyte Software	CGNT	22. nov 2024	7.82	-3.81
Cohen & Company	COHN	22. nov 2024	10.20	+5.04
Cohen & Steers	CNS	22. nov 2024	103.42	+1.40
Cohen & Steers Closedend Opportunity Fund	FOF	22. nov 2024	13.09	+0.61
Cohen & Steers Duration Pref and Income Fund	LDP	22. nov 2024	20.96	-0.24
Cohen & Steers Infrastructure Fund	UTF	22. nov 2024	25.78	+0.70
Cohen & Steers Qualityome Realty Fund	RQI	22. nov 2024	13.63	+1.34
Cohen & Steers Real Estate and Income Fund	RLTY	22. nov 2024	16.18	+0.62
Cohen & Steers REIT & Preferred & Income Fund	RNP	22. nov 2024	22.96	+0.83
Cohen & Steers Select and Income Fund	PSF	22. nov 2024	20.29	0.00
Cohen & Steers Tax-Advantaged Pref and Income Fund	PTA	22. nov 2024	20.00	-1.72
Cohen & Steers Total Return Realty Fund	RFI	22. nov 2024	12.85	+1.46
Cohen Circle Acquisition I Unit	CCIRU	22. nov 2024	10.01	0.00
Coherent	COHR	22. nov 2024	105.34	-0.36
Coherus BioSciences	CHRS	22. nov 2024	1.09	-0.91
Cohu	COHU	22. nov 2024	26.65	+2.11
Coinbase Global A	COIN	22. nov 2024	304.64	+3.19
Colgate-Palmolive	CL	22. nov 2024	94.92	+0.71
Coliseum Acquisition A	MITA	22. nov 2024	11.13	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.